Can a lactating mother safely use corticosteroids, and what dosing and timing precautions are recommended?

Use of Corticosteroids During Breastfeeding

Lactating mothers can safely use corticosteroids while breastfeeding, with prednisone or prednisolone ≤20 mg daily requiring no special precautions, and doses >20 mg daily requiring a 4-hour delay before breastfeeding. 1, 2

Preferred Corticosteroids for Breastfeeding

Prednisone and prednisolone are the corticosteroids of choice during lactation because they are minimally excreted into breast milk, with only approximately 10% of the maternal dose reaching the infant. 1, 3 This occurs because there is an equilibrium between prednisolone concentration in breast milk and maternal serum. 1

• Methylprednisolone is an acceptable alternative with a similar safety profile to prednisone/prednisolone. 3
• Avoid fluorinated corticosteroids (dexamethasone, betamethasone) during breastfeeding, as they cross more readily into breast milk and are not well metabolized. 3
• Hydrocortisone is compatible with breastfeeding when parenteral administration is necessary. 3

Dose-Specific Recommendations

Low-Dose Therapy (≤20 mg daily prednisone or equivalent)

Breastfeeding can continue without interruption or timing restrictions when the mother takes ≤20 mg daily of prednisone or equivalent non-fluorinated glucocorticoid. 1, 2, 3 The American College of Rheumatology gives this a strong recommendation. 1

High-Dose Therapy (>20 mg daily prednisone)

Women taking >20 mg daily should delay breastfeeding or discard breast milk obtained within 4 hours following medication administration. 1, 2 This timing recommendation is based on the peak concentration of prednisolone in breast milk, which occurs within the first 4 hours after maternal dosing. 1

• Peak milk concentrations occur at 1-2 hours post-dose, then decline progressively. 4
• Waiting 2-4 hours after infusion substantially limits infant exposure. 4

High-Dose Intravenous Methylprednisolone

For IV pulse methylprednisolone therapy (commonly used for multiple sclerosis relapses), the relative infant dose is only 0.71% of the weight-adjusted maternal dose. 4

• Breastfeeding 1 hour after infusion results in very low infant exposure. 4
• Waiting 2-4 hours after infusion further minimizes infant exposure. 4
• Methylprednisolone levels in milk were 2.100 µg/mL at 1 hour, declining to 0.680 µg/mL at 4 hours and 0.102 µg/mL at 12 hours. 4

Clinical Management Algorithm

1. Determine the minimum effective corticosteroid dose needed to control maternal disease. 1, 2

2. If ≤20 mg daily prednisone (or equivalent):

   • Continue breastfeeding without restrictions. 1, 2
   • No timing adjustments needed. 1

3. If >20 mg daily prednisone (or equivalent):

   • Administer medication immediately after a breastfeeding session. 2
   • Wait 4 hours before the next breastfeeding. 1, 2
   • Consider pumping and discarding milk during the 4-hour window if needed for comfort. 2

4. Monitor the infant for signs of drowsiness, poor feeding, or other adverse effects, though these are unlikely with appropriate dosing and timing. 1

Important Caveats and Pitfalls

Do not discourage breastfeeding due to necessary corticosteroid therapy. The benefits of breastfeeding are substantial, and maintaining maternal disease control with lactation-compatible medications is important for both mother and infant health. 1, 5

Avoid using higher doses than clinically necessary. The goal is to use the lowest effective dose to maintain disease control while minimizing infant exposure. 3

Do not confuse timing recommendations. The 4-hour delay applies only to doses >20 mg daily; lower doses require no special timing. 1, 2

Consider disease-modifying agents that are compatible with breastfeeding (hydroxychloroquine, azathioprine, TNF-α inhibitors) to allow for corticosteroid dose reduction. 1, 6

Consultation with the infant's pediatrician is encouraged when initiating or adjusting corticosteroid therapy during lactation. 5

Additional Compatible Medications During Breastfeeding

The American College of Rheumatology provides strong recommendations for the following medications as compatible with breastfeeding: hydroxychloroquine, infliximab, etanercept, adalimumab, golimumab, certolizumab, and rituximab. 1

Contraindicated medications during breastfeeding include leflunomide, mycophenolate mofetil, cyclophosphamide, and thalidomide (strong recommendation), as well as methotrexate (conditional recommendation). 1